Skip to main content

Table 4 Estimated hazard ratios of event incidence in the treatment group compared to control groups

From: Long-term effectiveness of a disease management program to prevent diabetic nephropathy: a propensity score matching analysis using administrative data in Japan

 

vs. Control group 1 Screened candidate

vs. Control group 2 Beneficiary within inclusion criteria

Diabetes-related complications (all)

1.14

(0.67–1.93)

0.60*

(0.36–1.00)

Ischemic heart disease

1.38

(0.48–3.93)

1.67

(0.56–5.02)

Stroke

0.43

(0.05–3.67)

0.21

(0.03–1.59)

Retinopathy requiring surgery

1.25

(0.53–2.97)

0.65

(0.27–1.59)

Neuropathy

2.71

(0.82–8.92)

1.49

(0.51–4.37)

End-stage renal disease requiring dialysis

0.63

(0.07–5.52)

0.15

(0.02–1.16)

Intensive care use

1.09

(0.48–2.45)

0.63

(0.28–1.43)

Emergency care use

0.79

(0.49–1.29)

0.59*

(0.37–0.94)

All-cause hospitalization

0.90

(0.69–1.18)

0.82

(0.63–1.06)

Dependency in activities of daily living

0.78

(0.22–2.80)

0.69

(0.20–2.38)

All-cause mortality

1.50

(0.51–4.41)

0.72

(0.27–1.90)

  1. *P < 0.05
  2. Adjusted for age, sex, diabetes medication, and Charlson comorbidity index